These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21339973)

  • 1. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging.
    Schlorf T; Meincke M; Kossel E; Glüer CC; Jansen O; Mentlein R
    Int J Mol Sci; 2010 Dec; 12(1):12-23. PubMed ID: 21339973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T].
    Ittrich H; Lange C; Dahnke H; Zander AR; Adam G; Nolte-Ernsting C
    Rofo; 2005 Aug; 177(8):1151-63. PubMed ID: 16021549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study.
    Boutry S; Brunin S; Mahieu I; Laurent S; Vander Elst L; Muller RN
    Contrast Media Mol Imaging; 2008; 3(6):223-32. PubMed ID: 19072771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages.
    Saito S; Tsugeno M; Koto D; Mori Y; Yoshioka Y; Nohara S; Murase K
    Int J Nanomedicine; 2012; 7():5415-21. PubMed ID: 23091384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency.
    Matuszewski L; Persigehl T; Wall A; Schwindt W; Tombach B; Fobker M; Poremba C; Ebert W; Heindel W; Bremer C
    Radiology; 2005 Apr; 235(1):155-61. PubMed ID: 15749976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
    Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging.
    Arbab AS; Wilson LB; Ashari P; Jordan EK; Lewis BK; Frank JA
    NMR Biomed; 2005 Oct; 18(6):383-9. PubMed ID: 16013087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison.
    Sun R; Dittrich J; Le-Huu M; Mueller MM; Bedke J; Kartenbeck J; Lehmann WD; Krueger R; Bock M; Huss R; Seliger C; Gröne HJ; Misselwitz B; Semmler W; Kiessling F
    Invest Radiol; 2005 Aug; 40(8):504-13. PubMed ID: 16024988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailoring the surface charge of dextran-based polymer coated SPIONs for modulated stem cell uptake and MRI contrast.
    Barrow M; Taylor A; Nieves DJ; Bogart LK; Mandal P; Collins CM; Moore LR; Chalmers JJ; Lévy R; Williams SR; Murray P; Rosseinsky MJ; Adams DJ
    Biomater Sci; 2015 Apr; 3(4):608-16. PubMed ID: 26222421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient and rapid labeling of transplanted cell populations with superparamagnetic iron oxide nanoparticles using cell surface chemical biotinylation for in vivo monitoring by MRI.
    So PW; Kalber T; Hunt D; Farquharson M; Al-Ebraheem A; Parkes HG; Simon R; Bell JD
    Cell Transplant; 2010; 19(4):419-29. PubMed ID: 20579412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging and biological properties of pancreatic islets labeled with iron oxide nanoparticles.
    Kim HS; Choi Y; Song IC; Moon WK
    NMR Biomed; 2009 Oct; 22(8):852-6. PubMed ID: 19489018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs.
    Lee JH; Jung MJ; Hwang YH; Lee YJ; Lee S; Lee DY; Shin H
    Biomaterials; 2012 Jun; 33(19):4861-71. PubMed ID: 22475532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety.
    Unterweger H; Dézsi L; Matuszak J; Janko C; Poettler M; Jordan J; Bäuerle T; Szebeni J; Fey T; Boccaccini AR; Alexiou C; Cicha I
    Int J Nanomedicine; 2018; 13():1899-1915. PubMed ID: 29636608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
    Zhang Q; Rajan SS; Tyner KM; Casey BJ; Dugard CK; Jones Y; Paredes AM; Clingman CS; Howard PC; Goering PL
    J Biomed Mater Res B Appl Biomater; 2016 Jul; 104(5):1032-42. PubMed ID: 26013845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
    Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
    Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron oxide based MR contrast agents: from chemistry to cell labeling.
    Laurent S; Boutry S; Mahieu I; Vander Elst L; Muller RN
    Curr Med Chem; 2009; 16(35):4712-27. PubMed ID: 19903138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transmission electron microscopy in the structural study of superparamagnetic contrast agents for MRI].
    Lucet I; Filmon R; Pouliquen D; Le Jeune JJ; Jallet P
    Bull Assoc Anat (Nancy); 1994 Mar; 78(240):57-9. PubMed ID: 7519906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content.
    Wabler M; Zhu W; Hedayati M; Attaluri A; Zhou H; Mihalic J; Geyh A; DeWeese TL; Ivkov R; Artemov D
    Int J Hyperthermia; 2014 May; 30(3):192-200. PubMed ID: 24773041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiolated polyacrylic acid-modified iron oxide nanoparticles for in vitro labeling and MRI of stem cells.
    Vetter A; Reinisch A; Strunk D; Kremser C; Hahn HW; Huck CW; Ostermann T; Leithner K; Bernkop-Schnürch A
    J Drug Target; 2011 Aug; 19(7):562-72. PubMed ID: 21174635
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.